Dr. Josef Parvizi, MD, PhD

Dr. Parvizi practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Parvizi's NPI, 1386864734, was assigned on April 26, 2007. Dr. Parvizi graduated from University of Oslo Faculty of Medicine in 1995. Dr. Parvizi holds California license A94400.

Dr. Parvizi's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Parvizi's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Parvizi to 1 more hospital, named with a free account. Dr. Parvizi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parvizi practices, 2 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Parvizi's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Parvizi is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Parvizi is licensed in California.

Dmand AI lists epilepsy and seizures among the conditions Dr. Parvizi treats.

CMS data shows 133 Medicare services from Dr. Parvizi across 3 procedure codes in 2024, for 117 Medicare patients. Medicare paid $17,099 for them.

CMS counts 117 Medicare patients who saw Dr. Parvizi in 2024. The largest group is under 65, with 50 patients. 60% of them have high cholesterol, and 56% have high blood pressure. 56% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parvizi's median patient age at 46, with 50% women.

In 2024, Dr. Parvizi wrote 970 Medicare Part D claims for 79 patients. 86% of them were for generic drugs. CMS names the drug for 877 of them, across 23 drugs with 11 or more claims each, at $201,266 in total drug cost. In 2023, CMS named 581 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Parvizi for performance year 2024, reported as part of a group. Dr. Parvizi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Parvizi as offering telehealth.

Dmand AI links 148 papers to Dr. Parvizi, published from 2003 to 2025. 2018 was the busiest year, with 20. The most frequent topics are Brain Mapping, Electroencephalography and Brain. Dr. Parvizi has published most often in J Neurosci. Dr. Parvizi's most frequent co-authors are Vivek P. Buch, MD, Nathan Earl Crone, MD and Kai Joshua Miller, MD, PhD.

CMS Open Payments shows 64 general payments to Dr. Parvizi from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 94% of the total. Ceribell, Inc. paid the most, $430,253.

Dr. Parvizi graduated from University of Oslo Faculty of Medicine in 1995.

Dr. Parvizi is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.